Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valrubicin cream Psoriasis plaque test phase IIa study
2007-005035-29Phase 2Completed
- Sponsor
- ValDerm
- Start
- Sep 2007
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of valrubicin in plaque psoriasis (6 arms), sponsored by ValDerm. Started Sep 2007; status: completed.
02
Drugs
valrubicin
03
Conditions
plaque psoriasis
Beyond the preview
Go deeper on 2007-005035-29.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005035-29.